Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-12-01
1997-07-08
Springer, David B.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514314, C07D40112, C07D21514, A61K 3147
Patent
active
056461623
ABSTRACT:
Oxy-phenyl-(phenyl)gycinolamides with heterocyclic substituents are prepared by reaction of the corresponding oxyphenylcarboxylic acids with heterocyclic substituents with phenylglycinol. The new substances are suitable as active compounds in medicaments, in particular in agents having an antiatherosclerotic action.
REFERENCES:
patent: 4929626 (1990-05-01), Mohrs et al.
patent: 4929629 (1990-05-01), Jeffery
patent: 4970215 (1990-11-01), Mohrs et al.
patent: 5091391 (1992-02-01), Raddatz et al.
patent: 5126354 (1992-06-01), Mohrs et al.
patent: 5192771 (1993-03-01), Mohrs et al.
patent: 5292769 (1994-03-01), Mohrs et al.
patent: 5304563 (1994-04-01), Raddatz et al.
patent: 5473076 (1995-12-01), Decker et al.
The Journal of Cell Biology, vol. 50, (1971), pp. 172-186.
Beuck Martin
Bischoff Hilmar
Connell Richard
Denzer Dirk
Goldmann Siegfried
Bayer Aktiengesellschaft
Springer David B.
LandOfFree
Oxy-phenyl-(phenyl)glycinolamides with heterocyclic substituents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oxy-phenyl-(phenyl)glycinolamides with heterocyclic substituents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxy-phenyl-(phenyl)glycinolamides with heterocyclic substituents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2409074